Sales decline 6.35% to Rs 27.27 crore
Posts in category Business Standard
Patel Engineering consolidated net profit rises 53.05% in the March 2024 quarter (18-05-2024)
Sales rise 11.46% to Rs 1343.18 crore
Vindhya Telelinks Ltd leads losers in ‘B’ group (18-05-2024)
Semac Consultants Ltd, N K Industries Ltd, International Conveyors Ltd and MRO-TEK Realty Ltd are among the other losers in the BSE’s ‘B’ group today, 18 May 2024.
Volumes soar at MTAR Technologies Ltd counter (18-05-2024)
MTAR Technologies Ltd recorded volume of 2.54 lakh shares by 12:49 IST on NSE, a 1.56 times surge over two-week average daily volume of 1.62 lakh shares
Dodla Dairy consolidated net profit rises 107.86% in the March 2024 quarter (18-05-2024)
Sales rise 8.72% to Rs 787.45 crore
Jain Irrigation Systems reports consolidated net loss of Rs 8.79 crore in the March 2024 quarter (18-05-2024)
Sales decline 1.08% to Rs 1726.57 crore
Ujjivan Small Finance Bank standalone net profit rises 6.50% in the March 2024 quarter (18-05-2024)
Total Operating Income rise 29.01% to Rs 1528.51 crore
Sensex gains 89 pts, Nifty ends above 22,500 in special trading session (18-05-2024)
Domestic stocks capped off the special trading session with small gains, extending their winning streak to three days. The Nifty 50 settled near its opening price after an initial jump, but broader market ended firm. Realty and pharma stocks led the charge, while financials took a breather. The overall sentiment was buoyed by the Dow Jones’ record close. A welcome sign is foreign investors returning to the buying side, easing some pressure on the market.
Aurobindo Pharma Ltd spurts 3.21% (18-05-2024)
Aurobindo Pharma Ltd is quoting at Rs 1202.4, up 3.21% on the day as on 12:49 IST on the NSE. The stock is up 103.78% in last one year as compared to a 23.61% spurt in NIFTY and a 57.6% spurt in the Nifty Pharma index.
Glenmark Pharmaceuticals Ltd up for third straight session (18-05-2024)
Glenmark Pharmaceuticals Ltd is quoting at Rs 1042.45, up 2.25% on the day as on 12:48 IST on the NSE. The stock is up 66.98% in last one year as compared to a 23.61% jump in NIFTY and a 57.6% jump in the Nifty Pharma index.